- Home
- GCT vs EYPT Comparison
GCT vs EYPT Comparison
Compare GCT & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCT
- EYPT
- Stock Information
- Founded
- GCT 2019
- EYPT 1987
- Country
- GCT United States
- EYPT United States
- Employees
- GCT N/A
- EYPT N/A
- Industry
- GCT Catalog/Specialty Distribution
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- GCT Consumer Discretionary
- EYPT Industrials
- Exchange
- GCT Nasdaq
- EYPT Nasdaq
- Market Cap
- GCT 685.2M
- EYPT 579.4M
- IPO Year
- GCT 2022
- EYPT 2005
- Fundamental
- Price
- GCT $20.73
- EYPT $10.36
- Analyst Decision
- GCT Buy
- EYPT Strong Buy
- Analyst Count
- GCT 2
- EYPT 8
- Target Price
- GCT $20.50
- EYPT $24.75
- AVG Volume (30 Days)
- GCT 690.0K
- EYPT 811.1K
- Earning Date
- GCT 08-05-2025
- EYPT 08-06-2025
- Dividend Yield
- GCT N/A
- EYPT N/A
- EPS Growth
- GCT 19.58
- EYPT N/A
- EPS
- GCT 3.07
- EYPT N/A
- Revenue
- GCT $1,181,871,000.00
- EYPT $56,042,000.00
- Revenue This Year
- GCT $1.98
- EYPT N/A
- Revenue Next Year
- GCT $6.50
- EYPT N/A
- P/E Ratio
- GCT $6.76
- EYPT N/A
- Revenue Growth
- GCT 42.89
- EYPT 12.04
- 52 Week Low
- GCT $11.17
- EYPT $3.91
- 52 Week High
- GCT $32.43
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- GCT 61.16
- EYPT 61.63
- Support Level
- GCT $19.61
- EYPT $9.45
- Resistance Level
- GCT $21.37
- EYPT $11.69
- Average True Range (ATR)
- GCT 0.96
- EYPT 0.83
- MACD
- GCT 0.07
- EYPT 0.03
- Stochastic Oscillator
- GCT 85.68
- EYPT 64.53
About GCT GigaCloud Technology Inc
GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.